BIO vs VLTO · rev $651.0M vs P/E 29, rev $5.50B
BIO (BIO) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported VLTO revenue for 2025-12-31 was $5.50B. Net income was $940.0M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
BIO currently screens at market cap $0. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the BIO and VLTO stock pages for the full models.
Not investment advice.